Home » Topics » Regulatory » Patents

Patents
RSS

Amgen identifies KRAS mutant inhibitors

April 5, 2019

Bluevalley Pharmaceutical discloses ATR inhibitors

April 4, 2019

U.S. researchers synthesize antisense oligonucleotides targeting MYC

April 4, 2019

TNFRSF18-targeting shRNAs described in Shenzhen Biocan Technologies patent

April 4, 2019

Shenzhen Biocan Technologies identifies new IDO-targeting shRNAs

April 4, 2019

Shenzhen Biocan Technologies patents APP-targeting shRNAs

April 4, 2019

ProQR Therapeutics discloses new HTT-targeting antisense oligonucleotides

April 3, 2019

Mologen synthesizes new TLR9 agonists

April 3, 2019

Altor BioScience identifies new fusion proteins for treatment of cancer

April 3, 2019

Stoke Therapeutics divulges new antisense oligomers

April 3, 2019

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...